# Implantation or Injectable Dosage Form New Animal Drugs; Hyaluronate Sodium Injection
> **Food and Drug Administration** · Final rule. · Published 2006-01-11 · Effective 2006-01-11 · 71 FR 1689
## Document
- **Document number:** 06-229
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 71 FR 1689
- **CFR reference:** 21 CFR 522
- **Publication date:** 2006-01-11
- **Effective date:** 2006-01-11
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer HealthCare LLC. The supplemental NADA provides for veterinary prescription use of a hyaluronate sodium solution, formulated with a benzyl alcohol preservative, for intravenous administration to horses for the treatment of osteoarthritis.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2006/01/11/06-229/implantation-or-injectable-dosage-form-new-animal-drugs-hyaluronate-sodium-injection)
---
*AI Analytics · CC0 1.0*